BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 157 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $705,954 | +12.4% | 99,711 | +11.8% | 0.00% | – |
| Q2 2023 | $628,052 | -46.6% | 89,212 | -36.7% | 0.00% | -100.0% |
| Q1 2023 | $1,175,573 | -6.1% | 140,956 | +29.3% | 0.00% | 0.0% |
| Q4 2022 | $1,251,549 | +15.2% | 109,020 | +26.4% | 0.00% | 0.0% |
| Q3 2022 | $1,086,000 | -0.5% | 86,235 | -16.4% | 0.00% | 0.0% |
| Q2 2022 | $1,091,000 | -39.7% | 103,198 | -7.3% | 0.00% | 0.0% |
| Q1 2022 | $1,809,000 | +7.4% | 111,287 | -8.5% | 0.00% | 0.0% |
| Q4 2021 | $1,685,000 | -44.8% | 121,615 | -42.7% | 0.00% | 0.0% |
| Q3 2021 | $3,050,000 | +35.9% | 212,199 | +49.5% | 0.00% | 0.0% |
| Q2 2021 | $2,244,000 | +70.5% | 141,893 | +9.7% | 0.00% | 0.0% |
| Q1 2021 | $1,316,000 | +23.5% | 129,321 | -9.6% | 0.00% | 0.0% |
| Q4 2020 | $1,066,000 | +180.5% | 143,078 | +29.5% | 0.00% | – |
| Q3 2020 | $380,000 | -26.6% | 110,495 | +1.5% | 0.00% | – |
| Q2 2020 | $518,000 | -88.8% | 108,887 | -95.3% | 0.00% | -100.0% |
| Q1 2020 | $4,641,000 | -64.6% | 2,320,459 | -39.0% | 0.00% | -55.6% |
| Q4 2019 | $13,119,000 | +1137.6% | 3,803,254 | +926.2% | 0.01% | +800.0% |
| Q3 2019 | $1,060,000 | +18.3% | 370,611 | +56.3% | 0.00% | 0.0% |
| Q2 2019 | $896,000 | -55.9% | 237,089 | -5.2% | 0.00% | 0.0% |
| Q1 2019 | $2,034,000 | +149.3% | 250,182 | +147.2% | 0.00% | 0.0% |
| Q4 2018 | $816,000 | -89.4% | 101,210 | -90.0% | 0.00% | -50.0% |
| Q3 2018 | $7,715,000 | +13.8% | 1,011,397 | -14.6% | 0.00% | 0.0% |
| Q2 2018 | $6,782,000 | +54.5% | 1,183,712 | +28.6% | 0.00% | 0.0% |
| Q1 2018 | $4,390,000 | +70.6% | 920,734 | +75.5% | 0.00% | 0.0% |
| Q4 2017 | $2,573,000 | +93.2% | 524,666 | +106.1% | 0.00% | +100.0% |
| Q3 2017 | $1,332,000 | -53.8% | 254,519 | -51.0% | 0.00% | -50.0% |
| Q2 2017 | $2,886,000 | +53.7% | 519,304 | +132.2% | 0.00% | +100.0% |
| Q1 2017 | $1,878,000 | -42.6% | 223,678 | -56.8% | 0.00% | -66.7% |
| Q4 2016 | $3,273,000 | +43.5% | 517,529 | -0.0% | 0.00% | +50.0% |
| Q3 2016 | $2,281,000 | +223.5% | 517,597 | +107.3% | 0.00% | – |
| Q2 2016 | $705,000 | -13.7% | 249,725 | -13.8% | 0.00% | -100.0% |
| Q1 2016 | $817,000 | -21.1% | 289,857 | +188.2% | 0.00% | 0.0% |
| Q4 2015 | $1,035,000 | -32.8% | 100,565 | -25.7% | 0.00% | 0.0% |
| Q3 2015 | $1,540,000 | +14.4% | 135,354 | +49.8% | 0.00% | 0.0% |
| Q2 2015 | $1,346,000 | +295.9% | 90,361 | +138.6% | 0.00% | – |
| Q1 2015 | $340,000 | +161.5% | 37,875 | +250.7% | 0.00% | – |
| Q4 2014 | $130,000 | -67.5% | 10,800 | -73.8% | 0.00% | – |
| Q3 2014 | $400,000 | +63.9% | 41,150 | +113.0% | 0.00% | – |
| Q2 2014 | $244,000 | -75.2% | 19,316 | -79.3% | 0.00% | -100.0% |
| Q1 2014 | $985,000 | +527.4% | 93,221 | +348.8% | 0.00% | – |
| Q4 2013 | $157,000 | +3040.0% | 20,773 | +2867.6% | 0.00% | – |
| Q3 2013 | $5,000 | – | 700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 1,105,673 | $8,237,000 | 6.28% |
| Sarissa Capital Management LP | 8,175,000 | $60,903,000 | 6.22% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,980,870 | $22,207,000 | 2.78% |
| DG Capital Management, LLC | 1,075,732 | $8,014,000 | 1.70% |
| Ghost Tree Capital, LLC | 900,000 | $6,705,000 | 1.49% |
| Parkman Healthcare Partners LLC | 538,370 | $4,011,000 | 1.03% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,835,810 | $43,477,000 | 0.86% |
| Formidable Asset Management, LLC | 470,419 | $3,470,000 | 0.80% |
| KNOTT DAVID M | 219,461 | $1,635,000 | 0.74% |
| Altium Capital Management LP | 250,000 | $1,863,000 | 0.70% |